DE69808620D1 - Universell verwendbares bluttplasma - Google Patents

Universell verwendbares bluttplasma

Info

Publication number
DE69808620D1
DE69808620D1 DE69808620T DE69808620T DE69808620D1 DE 69808620 D1 DE69808620 D1 DE 69808620D1 DE 69808620 T DE69808620 T DE 69808620T DE 69808620 T DE69808620 T DE 69808620T DE 69808620 D1 DE69808620 D1 DE 69808620D1
Authority
DE
Germany
Prior art keywords
blood
blood plasma
universally applicable
plasma
applicable blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69808620T
Other languages
English (en)
Other versions
DE69808620T2 (de
DE69808620T3 (de
Inventor
Wolfgang Marguerre
Tor-Einar Svae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Octapharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69808620(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma AG filed Critical Octapharma AG
Application granted granted Critical
Publication of DE69808620D1 publication Critical patent/DE69808620D1/de
Publication of DE69808620T2 publication Critical patent/DE69808620T2/de
Publication of DE69808620T3 publication Critical patent/DE69808620T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)
DE69808620T 1997-08-05 1998-08-04 Universell verwendbares bluttplasma Expired - Lifetime DE69808620T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97113466 1997-08-05
EP97113466A EP0896824A1 (de) 1997-08-05 1997-08-05 Universell verwendbares Bluttplasma
PCT/EP1998/004841 WO1999007390A1 (en) 1997-08-05 1998-08-04 A universally applicable blood plasma

Publications (3)

Publication Number Publication Date
DE69808620D1 true DE69808620D1 (de) 2002-11-14
DE69808620T2 DE69808620T2 (de) 2003-06-26
DE69808620T3 DE69808620T3 (de) 2008-05-21

Family

ID=8227172

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69808620T Expired - Lifetime DE69808620T3 (de) 1997-08-05 1998-08-04 Universell verwendbares bluttplasma

Country Status (25)

Country Link
US (1) US20110008459A1 (de)
EP (2) EP0896824A1 (de)
JP (1) JP2001513507A (de)
CN (1) CN1272061A (de)
AT (1) ATE225665T1 (de)
AU (1) AU742427B2 (de)
BG (1) BG64350B1 (de)
BR (1) BR9811839A (de)
CA (1) CA2299421C (de)
CZ (1) CZ293726B6 (de)
DE (1) DE69808620T3 (de)
DK (1) DK0991416T4 (de)
EA (1) EA003182B1 (de)
ES (1) ES2185218T5 (de)
HK (1) HK1026146A1 (de)
HU (1) HU226548B1 (de)
ID (1) ID24308A (de)
IL (1) IL134308A (de)
NO (1) NO326216B1 (de)
NZ (1) NZ502661A (de)
PL (1) PL193983B1 (de)
PT (1) PT991416E (de)
RS (1) RS50016B (de)
TW (1) TW555563B (de)
WO (1) WO1999007390A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
ES2281848T3 (es) * 2003-12-19 2007-10-01 Octapharma Ag Plasma sanguineo universalmente aplicable, virus inactivado producido a partir de porciones de plasma de no caucasicos.
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
ES2684130T3 (es) * 2009-04-09 2018-10-01 Entegrion, Inc. Productos de la sangre secados por aspersión y métodos para elaborar los mismos
US8407912B2 (en) 2010-09-16 2013-04-02 Velico Medical, Inc. Spray dried human plasma
WO2011035062A2 (en) 2009-09-16 2011-03-24 Velico Medical, Inc. Spray dried human plasma
FR2963737B1 (fr) * 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
CA2816090A1 (en) 2010-10-29 2012-05-03 Velico Medical, Inc. System and method for spray drying a liquid
US20140083628A1 (en) 2012-09-27 2014-03-27 Velico Medical, Inc. Spray drier assembly for automated spray drying
US9561184B2 (en) 2014-09-19 2017-02-07 Velico Medical, Inc. Methods and systems for multi-stage drying of plasma
FR3026950A1 (fr) 2014-10-09 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de plasma universel
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
FR3083121B1 (fr) 2018-06-27 2021-10-22 Maco Pharma Sa Procede de greffage d un element fibreux pour l elimination d anticorps du sang ou d un composant sanguin
JP7471316B2 (ja) 2019-03-14 2024-04-19 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー マルチパート凍結乾燥容器
DE102020212609B3 (de) * 2020-10-06 2022-04-07 Universität Greifswald Verfahren und Vorrichtung zur Herstellung von Universalplasma
US12083447B2 (en) 2022-09-15 2024-09-10 Velico Medical, Inc. Alignment of a disposable for a spray drying plasma system
US11975274B2 (en) 2022-09-15 2024-05-07 Velico Medical, Inc. Blood plasma product
US11998861B2 (en) 2022-09-15 2024-06-04 Velico Medical, Inc. Usability of a disposable for a spray drying plasma system
US11841189B1 (en) 2022-09-15 2023-12-12 Velico Medical, Inc. Disposable for a spray drying system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
JPH0723319B2 (ja) * 1986-05-14 1995-03-15 株式会社ミドリ十字 血液製剤から血液型抗体を除去する方法
DE4008852A1 (de) † 1990-03-20 1991-09-26 Octapharma Ag Verfahren zur herstellung von nicht-infektioesem blutplasma
US5217627A (en) * 1990-11-06 1993-06-08 Pall Corporation System and method for processing biological fluid
JP3575770B2 (ja) * 1992-03-31 2004-10-13 学校法人藤田学園 血漿由来製剤
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors

Also Published As

Publication number Publication date
DE69808620T2 (de) 2003-06-26
EP0991416A1 (de) 2000-04-12
HUP0004795A3 (en) 2003-08-28
EP0896824A1 (de) 1999-02-17
ES2185218T5 (es) 2008-04-16
IL134308A (en) 2004-09-27
YU5800A (sh) 2003-02-28
CA2299421A1 (en) 1999-02-18
ATE225665T1 (de) 2002-10-15
EP0991416B2 (de) 2007-10-31
DE69808620T3 (de) 2008-05-21
BG104117A (en) 2000-12-29
IL134308A0 (en) 2001-04-30
CZ2000370A3 (cs) 2000-09-13
EA200000196A1 (ru) 2000-10-30
PL338794A1 (en) 2000-11-20
CN1272061A (zh) 2000-11-01
BG64350B1 (bg) 2004-11-30
EA003182B1 (ru) 2003-02-27
NZ502661A (en) 2001-03-30
TW555563B (en) 2003-10-01
CZ293726B6 (cs) 2004-07-14
WO1999007390A1 (en) 1999-02-18
DK0991416T3 (da) 2003-02-10
US20110008459A1 (en) 2011-01-13
NO20000578L (no) 2000-03-27
EP0991416B1 (de) 2002-10-09
NO20000578D0 (no) 2000-02-04
RS50016B (sr) 2008-09-29
ID24308A (id) 2000-07-13
PT991416E (pt) 2003-02-28
HK1026146A1 (en) 2000-12-08
AU742427B2 (en) 2002-01-03
PL193983B1 (pl) 2007-04-30
ES2185218T3 (es) 2003-04-16
NO326216B1 (no) 2008-10-20
HUP0004795A2 (hu) 2001-04-28
DK0991416T4 (da) 2008-02-25
HU226548B1 (en) 2009-03-30
JP2001513507A (ja) 2001-09-04
CA2299421C (en) 2009-11-10
BR9811839A (pt) 2000-08-15
AU9256998A (en) 1999-03-01

Similar Documents

Publication Publication Date Title
DE69808620D1 (de) Universell verwendbares bluttplasma
FI980112A (fi) Antiparasiittiset markfortiinit ja paraherkvamidit
ID21924A (id) Olanzapin dihidrat d
KR960702948A (ko) 바이폴라 트랜지스터용 측면 경사에미터(laterally graded emitter for bipolar transistor)
ITRM950541A0 (it) Miscela di aerazione. (caso 154-0272)
KR950701162A (ko) 카르테시안 멀티 캐리어 피드백(cartesian multicarrier feedback)
DK0655454T3 (da) Fremgangsmåde til fremstilling af 2,2-difluorketensilylacetaler og alfa,alfa-difluor-beta-silyloxy-1,3-dioxolan-4-propansyreestere
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DE69402201D1 (de) Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
TR199701298T1 (xx) Tetralinler.
FI900097A0 (fi) Foerfarande foer bestaemning av den fibrin upploesande totalaktiviteten i plasma.
DE69012619D1 (de) Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen.
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
ES2073495T3 (es) Benzotiazepinas.
DE69320095D1 (de) 3,9-Bis(Dialkylamino)-2,4,8,10-Tetraoxa-3,9-Diphosphaspiro 5.5-Undecane und stabilisierte Zusammensetzung
DK0783491T3 (da) Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid
DK0771786T3 (da) Fremstilling af aryl- og vinylnitriler
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose
TR199801087T2 (xx) 4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il
ES1025316Y (es) Ambientador mejorado.
TR27159A (tr) Sübstitüe edilmis 2 -fenil-5-(3-fenoksifelin (1,1,1-trifloropentanlari hazirlamaya mahsus yöntem ve aramaddeler.
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings